BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34939837)

  • 21. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotherapeutic approach to treat diabetic foot ulcers using tissue-engineered nanofiber skin substitutes: A review.
    Bahmad HF; Poppiti R; Alexis J
    Diabetes Metab Syndr; 2021; 15(2):487-491. PubMed ID: 33668000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Debridement of Diabetic Foot Ulcers.
    Dayya D; O'Neill OJ; Huedo-Medina TB; Habib N; Moore J; Iyer K
    Adv Wound Care (New Rochelle); 2022 Dec; 11(12):666-686. PubMed ID: 34376065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of diabetic foot ulcers: review of the literature with regard to the TIME clinical decision support tool.
    Patton D; Avsar P; Wilson P; Mairghani M; O'Connor T; Nugent L; Moore Z
    J Wound Care; 2022 Sep; 31(9):771-779. PubMed ID: 36113541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
    Rai V; Moellmer R; Agrawal DK
    Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of medical-grade maggots in facilitating healing of diabetic foot ulcers in Kano, northern Nigeria: a case series.
    Yusuf MA; Ibrahim BM; Abubakar F; Ibrahim M; Sheshe AA; Abubakar MK; Aji SA; Gbadamasi KA; Busayo JK; Sallau SB; Ridwan BA; Uloko AE; Gezawa ID; Ramalan M; Sidi K; Abdullahi S; Adamu KM; Bello N; Muhammad A; Mukhtar R; Aina D
    J Wound Care; 2024 Feb; 33(Sup2):S24-S30. PubMed ID: 38348863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Promising Hydrogel Candidates for Preclinically Treating Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.
    Wu H; Ni R; Shi Y; Hu Y; Shen Z; Pang Q; Zhu Y
    Adv Wound Care (New Rochelle); 2023 Jan; 12(1):28-37. PubMed ID: 35229628
    [No Abstract]   [Full Text] [Related]  

  • 29. Updating the Diabetic Foot Treatment Algorithm: Recommendations on Treatment Using Advanced Medicine and Therapies.
    Blume P; Wu S
    Wounds; 2018 Feb; 30(2):29-35. PubMed ID: 29091034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of repeated remote ischemic conditioning on diabetic foot ulcers: A proof-of-concept study.
    Regulski M; Greenwood T; Leschinsky B
    Wound Repair Regen; 2021 Sep; 29(5):853-858. PubMed ID: 34236750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status and progress in research on dressing management for diabetic foot ulcer.
    Jiang P; Li Q; Luo Y; Luo F; Che Q; Lu Z; Yang S; Yang Y; Chen X; Cai Y
    Front Endocrinol (Lausanne); 2023; 14():1221705. PubMed ID: 37664860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus.
    Tsourdi E; Barthel A; Rietzsch H; Reichel A; Bornstein SR
    Biomed Res Int; 2013; 2013():385641. PubMed ID: 23653894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic foot ulcer: treatment challenges.
    Bolton L
    Wounds; 2022 Jun; 34(6):175-177. PubMed ID: 35881427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights.
    Baltzis D; Eleftheriadou I; Veves A
    Adv Ther; 2014 Aug; 31(8):817-36. PubMed ID: 25069580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem Cells and Angiogenesis: Implications and Limitations in Enhancing Chronic Diabetic Foot Ulcer Healing.
    Rai V; Moellmer R; Agrawal DK
    Cells; 2022 Jul; 11(15):. PubMed ID: 35892584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of UrgoStart Plus dressings in real-life conditions: results of a prospective multicentre study on 961 patients.
    Augustin M; Keuthage W; Lobmann R; Lützkendorf S; Groth H; Möller U; Thomassin L; Bohbot S; Dissemond J; Blome C
    J Wound Care; 2021 Dec; 30(12):966-978. PubMed ID: 34881999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative pressure wound therapy: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(14):1-38. PubMed ID: 23074484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Dermoepidermal Skin Substitutes for Diabetic Foot Ulcers.
    Álvaro-Afonso FJ; García-Álvarez Y; Lázaro-Martínez JL; Kakagia D; Papanas N
    Curr Vasc Pharmacol; 2020; 18(2):182-192. PubMed ID: 30963977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.